SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Net Sales | ₹126 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
What is the latest Revenue of SHREE GANESH REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹126 Cr |
| Mar2024 | ₹6,401,872 Cr |
| Mar2020 | ₹35 Cr |
| Mar2019 | ₹35 Cr |
How is Revenue of SHREE GANESH REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹126 Cr | -100.00 | |
| Mar2024 | ₹6,401,872 Cr | 18,128,325.92 | |
| Mar2020 | ₹35 Cr | 0.00 | |
| Mar2019 | ₹35 Cr | - | |
Compare Revenue of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹813.8 Cr | -5% | -9.6% | 9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -5% |
-9.6% |
9.9% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses